Rare Cancer News & Clinical Trials » Trial

Trial - Brain Tumor (100 unread)

1 2 3 ... 13

Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients

Posted: December 4th, 2023, 3:00am GMT

Conditions: Breast Cancer Stage 2 and 3
Interventions: Drug: Fenofibrate; Other: Placebo; Drug: Doxorubicin; Drug: Cyclophosphamide
Sponsors: Tanta University
Not yet recruiting
Pyrotinib Combined With Capecitabine and Bevacizumab for Patients With HER2 Positive Breast Cancer and Brain Metastases

Posted: December 1st, 2023, 3:00am GMT

Conditions: Breast Cancer With Brain Metastases
Interventions: Drug: pyrotinib+capecitabine+bevacizumab
Sponsors: Tongji Hospital
Recruiting
Restricted Eating Time in the Treatment of Type 2 Diabetes

Posted: November 30th, 2023, 3:00am GMT

Conditions: Type 2 Diabetes
Interventions: Other: Time restricted eating
Sponsors: Steno Diabetes Center Copenhagen; University of Leeds; Salk Institute for Biological Studies; University of Copenhagen; Glostrup University Hospital, Copenhagen
Not yet recruiting
BraiN20® Monitoring in Acute Stroke Undergoing Thrombectomy

Posted: November 29th, 2023, 3:00am GMT

Conditions: Acute Stroke; Mechanical Thrombectomy
Interventions: Device: BraiN20(R) monitoring of N20 somatosensory evoked potential
Sponsors: Fundació Institut Germans Trias i Pujol; European Innovation Council; Anagram-ESIC
Recruiting
A Study of Metabolic Agents Following Brain Radiation

Posted: November 29th, 2023, 3:00am GMT

Conditions: CNS Malignancy
Interventions: Diagnostic Test: F-DOPA Positron Emission Tomography; Diagnostic Test: Chemical Exchange Saturation Transfer Magnetic Resonance Imaging
Sponsors: Mayo Clinic
Enrolling by invitation
[18F]BF3-BPA Injection for PET Imaging Study of Gliomas in the Brain

Posted: November 28th, 2023, 3:00am GMT

Conditions: Cerebral Gliosis; Positron Emission Tomography
Interventions: Radiation: [18F]BF3-BPA Injection for PET Imaging
Sponsors: Huashan Hospital
Recruiting
The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)

Posted: November 27th, 2023, 3:00am GMT

Conditions: Glioblastoma; Glioblastoma, IDH-wildtype; Glioblastoma Multiforme; Glioblastoma Multiforme, Adult; Glioblastoma Multiforme of Brain
Interventions: Procedure: Tumor resection; Procedure: Tumor biopsy
Sponsors: Jasper Gerritsen; Haaglanden Medical Centre; Universitaire Ziekenhuizen KU Leuven; University Hospital Heidelberg; Technical University of Munich; Insel Gruppe AG, University Hospital Bern; Massachusetts General Hospital; University of California, San Francisco
Recruiting
Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders

Posted: November 27th, 2023, 3:00am GMT

Conditions: Invasive PreNatal Diagnosis in a Context of Family History of Single-gene Disorders, Including; Sickle Cell Disease; Cystic Fibrosis; Fragile X Syndrome; Proximal Spinal Muscular Atrophy; Myotonic Dystrophy; Muscular Dystrophy, Duchenne; Muscular Dystrophy, Becker; Neurofibromatosis-Noonan Syndrome; Huntington Disease; Hemophilia A; Hemophilia B; MODY2 Diabetes; X-Linked Hydrocephalus; Autosomal Recessive Polycystic Kidney Disease
Interventions: Biological: Blood sample
Sponsors: Assistance Publique - Hôpitaux de Paris
Not yet recruiting
Non-myeloablative Phase I/II Haploidentical HCT Study for Patients With Sickle Cell Disease, Including Compromised Organ Function

Posted: November 24th, 2023, 3:00am GMT

Conditions: Sickle Cell Disease
Interventions: Combination Product: Cohort 1; Combination Product: Cohort 2
Sponsors: National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting
Cognitive Function and Glymphatic System in Children With Epilepsy

Posted: November 22nd, 2023, 3:00am GMT

Conditions: Epilepsy; Cognitive Dysfunction; Seizure, Epileptic
Interventions: Device: Threshold IMT; Drug: Antiepileptic medication
Sponsors: Ege University
Not yet recruiting
The Effect of GD-iExo-003 in Acute Ischemic Stroke

Posted: November 20th, 2023, 3:00am GMT

Conditions: Acute Ischemic Stroke
Interventions: Drug: exosomes derived from human induced pluripotent stem cell for injection; Drug: a placebo of exosomes derived from human induced pluripotent stem cell for injection
Sponsors: Xuanwu Hospital, Beijing; Guidon Pharmaceutics Ltd.
Not yet recruiting
The Effects of Anesthetics on Brain Network Connectivity in Patients With Supratentorial Glioma

Posted: November 20th, 2023, 3:00am GMT

Conditions: Brain Network Connectivity; Postoperative Delirium; Dexmedetomidine; Propofol
Interventions: Drug: Dexmedetomidine; Drug: Propofol
Sponsors: Beijing Tiantan Hospital
Recruiting
Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With Radiochemotherapy and Maintenance Chemotherapy in Patients With Glioblastoma (Brain-RF)

Posted: November 20th, 2023, 3:00am GMT

Conditions: Glioblastoma
Interventions: Device: Radiofrequency electromagnetic field treatment
Sponsors: Charite University, Berlin, Germany
Recruiting
xPedite: An Observational Study to Expedite DIPG and DMG Research

Posted: November 20th, 2023, 3:00am GMT

Conditions: Oncology; DIPG; DMG
Sponsors: xCures; SonALAsense, Inc.
Not yet recruiting
Trotabresib in Combination With Vinorelbine and Radiation Therapy for the Treatment of HER2+ Breast Cancer With Central Nervous System or Leptomeningeal Metastasis

Posted: November 17th, 2023, 3:00am GMT

Conditions: Breast Carcinoma; Metastatic Malignant Neoplasm in the Brain; Metastatic Malignant Neoplasm in the Leptomeninges
Interventions: Procedure: Biospecimen Collection; Procedure: Computed Tomography; Procedure: Magnetic Resonance Imaging; Radiation: Radiation Therapy; Procedure: Resection; Drug: Trotabresib; Drug: Vinorelbine
Sponsors: Northwestern University; National Cancer Institute (NCI)
Not yet recruiting
Preoperative Preradiotherapy TTFields

Posted: November 17th, 2023, 3:00am GMT

Conditions: Glioblastoma
Interventions: Device: TTFields
Sponsors: The Christie NHS Foundation Trust; University of Manchester; Northern Care Alliance NHS Foundation Trust; NovoCure Ltd.
Not yet recruiting
Metastasis-directed Therapy for Oligometastases of Breast Cancer

Posted: November 16th, 2023, 3:00am GMT

Conditions: Breast Cancer; Oligometastasis; Metastatic Breast Cancer
Interventions: Drug: Systemic therapy for 12 weeks after primary registration; Procedure: Radiation therapy (SBRT/conventional RT); Procedure: Surgery; Drug: Same systemic therapy after secondary registration
Sponsors: Tokyo Medical and Dental University
Recruiting
Efficacy of T-Dxd in the Treatment of HER2-positive BCBM After Prior Pyrotinib

Posted: November 16th, 2023, 3:00am GMT

Conditions: Breast Cancer
Interventions: Drug: T-DXd
Sponsors: Beijing 302 Hospital
Recruiting
CONFIDENCE-AI Financial Education for Caregivers (CONFIDENCE-AI)

Posted: November 16th, 2023, 3:00am GMT

Conditions: Alzheimer Disease; Dementia; Caregiver Burden; Financial Stress
Interventions: Behavioral: CONFIDENCE-AI
Sponsors: Case Western Reserve University
Not yet recruiting
A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain

Posted: November 15th, 2023, 3:00am GMT

Conditions: Metastatic Renal Cell Carcinoma; Brain Metastases
Interventions: Drug: Cabozantinib; Device: Nivolumab; Radiation: Stereotactic Radiosurgery (SRS)
Sponsors: Memorial Sloan Kettering Cancer Center; Exelixis
Recruiting
Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial

Posted: November 15th, 2023, 3:00am GMT

Conditions: Low Grade Glioma; Malignant Brain Glioma; Malignant Brain Neoplasm; Meningioma
Interventions: Procedure: Biospecimen Collection; Procedure: Computed Tomography; Drug: Dexamethasone; Procedure: Magnetic Resonance Imaging; Other: Questionnaire Administration
Sponsors: Emory University; National Cancer Institute (NCI)
Not yet recruiting
Nutritional Therapy in Late-onset Pompe Disease

Posted: November 14th, 2023, 3:00am GMT

Conditions: Pompe Disease; Muscle Loss; Obesity; Nutrition Poor; Lysosomal Storage Diseases; Glycogen Storage Disease Type II; Glycogen Storage Disease Type II Late Onset; Glycogen Storage Disease Type II, Adult
Interventions: Dietary Supplement: Multi-ingredient supplement (PDT-MIS); Dietary Supplement: Placebo (PLA)
Sponsors: McMaster University
Not yet recruiting
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Posted: November 14th, 2023, 3:00am GMT

Conditions: Hematologic Malignancy; Leukemia; Lymphoma; Acute Lymphocytic Leukemia; ALL; Acute Myelogenous Leukemia; AML; Chronic Myelogenous Leukemia; CML; Myeloproliferative Neoplasm; Non Hodgkin Lymphoma; Hodgkin Lymphoma; Diffuse Large B Cell Lymphoma; Follicular Lymphoma; Burkitt Lymphoma; T-cell Lymphoma; B Cell Lymphoma; Peripheral T Cell Lymphoma; Cutaneous B-Cell Lymphoma
Interventions: Other: 1. Drug: The Venetoclax PK study is collecting bodily fluid samples (ie., whole blood and optional cerebrospinal fluid) of patients prescribed venetoclax as crushed tablets per standard of care.
Sponsors: Children's Hospital Medical Center, Cincinnati
Not yet recruiting
UCMSCs as Treatment for Patients With Acute Ischemic Stroke (Stroke Neuroncell-EX)

Posted: November 13th, 2023, 3:00am GMT

Conditions: Acute Ischemic Stroke
Interventions: Biological: Neuroncell-EX; Other: Placebo
Sponsors: Cytopeutics Sdn. Bhd.; National University of Malaysia
Not yet recruiting
Study of Oral JYP0322 in Patients With Locally Advanced or Metastatic Cancer Targeting ROS1 Molecular Fusion.

Posted: November 13th, 2023, 3:00am GMT

Conditions: Protein Kinase Inhibitors; Other Protocol Specified Criteria; Lung Neoplasms; Brain Neoplasms
Interventions: Drug: JYP0322
Sponsors: Guangzhou JOYO Pharma Co., Ltd
Recruiting
Glioblastoma Remote Monitoring and Care - Research Protocol

Posted: November 13th, 2023, 3:00am GMT

Conditions: Glioblastoma; Venous Thromboembolism; Seizures
Interventions: Device: Apple Watch
Sponsors: Case Comprehensive Cancer Center
Not yet recruiting
MRI Gadopiclenol Enhanced Imaging of CNS Tumors

Posted: November 10th, 2023, 3:00am GMT

Conditions: Image
Interventions: Device: CE MRI on 0.064T Scanner; Drug: Gadopiclenol
Sponsors: Medical University of South Carolina; Guerbet
Not yet recruiting
Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of the Oncolytic HSV1 MVR-C5252

Posted: November 10th, 2023, 3:00am GMT

Conditions: Recurrent High Grade Glioma
Interventions: Biological: MVR-C5252
Sponsors: Duke University
Not yet recruiting
Adebelizumab Combined With Chemotherapy and Radiotherapy Treat ES-SCLC

Posted: November 9th, 2023, 3:00am GMT

Conditions: Extensive Small Cell Lung Cancer
Interventions: Drug: Adebelizumab+Carboplatin+Etoposide+Concurrent Radiotherapy
Sponsors: Qianfoshan Hospital
Recruiting
Study of Human Brain-Gut Axis and Gut Microbiome in Patients With Brain Lesions - Repository for Neuroscience Research

Posted: November 6th, 2023, 3:00am GMT

Conditions: Malignant Central Nervous System Neoplasm
Interventions: Other: Non-Interventional Study
Sponsors: Mayo Clinic
Not yet recruiting
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients

Posted: November 6th, 2023, 3:00am GMT

Conditions: Glioblastoma; High-grade Glioma; Glioblastoma, IDH-wildtype; Glioblastoma, IDH-mutant; Glioblastoma Multiforme, Adult; Astrocytoma, Grade IV; Astrocytoma, Grade III; Astrocytoma, Malignant; Brain Neoplasms; Brain Neoplasm, Primary; Brain Neoplasms, Adult; Brain Neoplasm, Malignant
Interventions: Procedure: Supramaximal resection; Procedure: Maximal safe resection
Sponsors: Jasper Gerritsen; Haaglanden Medical Centre; Universitaire Ziekenhuizen KU Leuven; University Hospital Heidelberg; Technical University of Munich; Insel Gruppe AG, University Hospital Bern; Massachusetts General Hospital; University of California, San Francisco
Recruiting
IDEAL Study: Blinded RCT for the Impact of AI Model for Cerebral Aneurysms Detection on Patients' Diagnosis and Outcomes

Posted: November 6th, 2023, 3:00am GMT

Conditions: Intracranial Aneurysm; CT Angiography; Deep Learning; Double Bind Interaction
Interventions: Device: True-AI-integrated intracranial aneurysms diagnosis strategy; Device: Sham-AI-integrated intracranial aneurysms diagnosis strategy
Sponsors: Jinling Hospital, China
Not yet recruiting
First-in-human Experience Using Novel Ultraflexible Low-impedance Electrode Arrays: an IDEAL Stage 1 Study

Posted: November 3rd, 2023, 2:00am GMT

Conditions: Epilepsy; Focal Cortical Dysplasia
Interventions: Device: Insertion of electrode during planned neurosurgery for epilepsy
Sponsors: Great Ormond Street Hospital for Children NHS Foundation Trust
Not yet recruiting
Hodgkin's Disease and Chemotherapy Before 40 Years

Posted: November 3rd, 2023, 2:00am GMT

Conditions: Hodgkin Disease
Interventions: Other: Morphological and functional magnetic resonance imaging (MRI); Other: Neuropsychological assessment
Sponsors: Lille Catholic University
Not yet recruiting
Randomized Controlled Study Evaluating the Efficacy of Hypnosis in Nuclear Medicine

Posted: November 3rd, 2023, 2:00am GMT

Conditions: Cancer; Myocarditis; Alzheimer Disease; Parkinson
Interventions: Other: Ericksonian Hypnosis; Other: Hypnosis
Sponsors: Central Hospital, Nancy, France
Recruiting
Trial Comparing Systemic Therapy Alone and With Local Ablative Treatment for Stage IV NSCL Cancer Patients

Posted: November 2nd, 2023, 2:00am GMT

Conditions: Non-small Cell Lung Cancer (NSCLC); Stage IV
Interventions: Other: Systemic therapy alone or in combination with LAT (surgery and/or radiotherapy); Other: Surgery; Radiation: Radiotherapy
Sponsors: Swiss Group for Clinical Cancer Research
Not yet recruiting
Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study.

Posted: November 2nd, 2023, 2:00am GMT

Conditions: Glioblastoma
Interventions: Diagnostic Test: 18F-GE-180 PET; Diagnostic Test: Advanced MRI; Other: Collection of hematopoietic stem cells; Other: Blood withdrawal; Other: Collection of Cancer Stem Cells
Sponsors: Istituto Clinico Humanitas; Mediolanum Cardio Research
Not yet recruiting
Neurobehavioural and Cognitive Changes in Cancer Cachexia (CANCOG)

Posted: November 2nd, 2023, 2:00am GMT

Conditions: Cancer; Cachexia; Cachexia-Anorexia Syndrome; Appetite Loss; Weight Loss
Interventions: Procedure: MRI/ Functional MRI; Behavioral: Self-reported questionnaires; Behavioral: Computer based tasks
Sponsors: University of Cambridge
Not yet recruiting
PEPPI Study: Identification of Women at Risk for Placental Dysfunction

Posted: November 2nd, 2023, 2:00am GMT

Conditions: Pre-Eclampsia; Intrauterine Growth Restriction; Polycystic Ovary Syndrome; Iron-deficiency; Cardiovascular Diseases; Hypertensive Disorder of Pregnancy; Proteinuria in Pregnancy
Interventions: Other: Pre-eclampsia screening program
Sponsors: Oulu University Hospital; PerkinElmer, Inc.; Roche Diagnostics; Academy of Finland; Sigrid Jusélius Foundation; Finnish Medical Foundation; University of Oulu
Recruiting
The North Kynouria Project

Posted: November 2nd, 2023, 2:00am GMT

Conditions: Cardiovascular Diseases; Heart Diseases; Cerebrovascular Disease; Coronary Disease; Dyslipidemias; Stroke (CVA) or TIA; Myocardial Infarction; Hypertension; Diabetes Mellitus; Peripheral Artery Disease
Interventions: Behavioral: Patient counselling
Sponsors: University Hospital, Ioannina; Hellenic Stroke Organization; Municipality of North Kynouria; Greece 2021 Committee; Astros Health Care Center
Recruiting
Long-term Neurovascular Complications After Radiation Therapy in Head and Neck Cancer

Posted: November 1st, 2023, 2:00am GMT

Conditions: Radiation Treatment; Neurovascular Complications
Sponsors: Chang Gung Memorial Hospital
Recruiting
Stellate Ganglion Block in Parkinson's Disease

Posted: November 1st, 2023, 2:00am GMT

Conditions: Stellate Ganglion; Parkinson Disease
Interventions: Diagnostic Test: Treatment （Stellate ganglion block；Oral standard anti-Parkinson's drugs）; Diagnostic Test: Treatment （Oral standard anti-Parkinson's drugs）
Sponsors: Zhujiang Hospital
Recruiting
Phase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body Irradiation

Posted: October 31st, 2023, 2:00am GMT

Conditions: Extensive Stage Lung Small Cell Carcinoma; Stage IV Lung Cancer
Interventions: Drug: Carboplatin; Biological: Atezolizumab; Drug: Etoposide; Radiation: Total Body Irradiation; Radiation: Hypofractionated Radiation Therapy; Procedure: Magnetic Resonance Imaging
Sponsors: Vanderbilt-Ingram Cancer Center; Genentech, Inc.
Recruiting
Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma

Posted: October 30th, 2023, 2:00am GMT

Conditions: Glioblastoma; Anaplastic Astrocytoma; Astrocytoma; Anaplastic Oligodendroglioma
Interventions: Other: Adaptive Radiotherapy
Sponsors: Columbia University; Varian Medical Systems
Recruiting
Clinical Feasibility of Brain Radiotherapy Using Synthetic CTs in an MRI-only Workflow

Posted: October 30th, 2023, 2:00am GMT

Conditions: Brain Tumor, Primary; Brain Tumor - Metastatic
Interventions: Radiation: brain radiotherapy
Sponsors: University of Erlangen-Nürnberg Medical School
Not yet recruiting
Beetroot Juice Supplementation in Chronic Hypertensive Pregnancies

Posted: October 30th, 2023, 2:00am GMT

Conditions: Hypertension in Pregnancy; Hypertension; Pregnancy
Interventions: Dietary Supplement: Nitrate-enriched beetroot extract juice; Dietary Supplement: Placebo juice
Sponsors: University of Sao Paulo; Hospital das Clínicas de Ribeirão Preto
Not yet recruiting
A Study of Avutometinib for People With Solid Tumor Cancers

Posted: October 27th, 2023, 2:00am GMT

Conditions: Refractory Cancer; CNS Tumors; CNS Tumor, Adult; CNS Tumor, Childhood; MAP Kinase Family Gene Mutation; NF1; Plexiform Neurofibroma; Low-grade Glioma; Optic Pathway Gliomas; Neuroblastoma; Primary Brain Tumor; Solid Tumor; Solid Tumor, Adult; Solid Carcinoma; Central Nervous System Tumor
Interventions: Drug: Avutometinib
Sponsors: Memorial Sloan Kettering Cancer Center
Recruiting
Tumor Vaccines for Solid Tumors

Posted: October 26th, 2023, 2:00am GMT

Conditions: Glioma; Solid Tumor
Interventions: Biological: tumor vaccine; Radiation: Radiotherapy; Drug: Chemotherapy; Procedure: Surgery
Sponsors: Huashan Hospital
Recruiting
Dynamic Frailty Assessment for Guiding the Treatment in Older Adults With Newly Diagnosed Multiple Myeloma

Posted: October 25th, 2023, 2:00am GMT

Conditions: Multiple Myeloma; Frailty
Sponsors: FengYan Jin
Not yet recruiting
ASCENT Intervention for Brain Tumor Patients

Posted: October 25th, 2023, 2:00am GMT

Conditions: Malignant Brain Tumor; Glioma; Coping Skills; Distress, Emotional
Interventions: Behavioral: Psychosocial intervention; Other: Usual supportive care
Sponsors: Massachusetts General Hospital
Not yet recruiting
Discovery of New Cancer in the 1-year Follow-up After Ischemic Stroke in Patients at Risk: The INVISIBLE-1 Study

Posted: October 25th, 2023, 2:00am GMT

Conditions: Cancer-related Stroke; Paraneoplastic Coagulopathy; Occult Cancer; Ischemic Stroke; Embolic Stroke of Undetermined Source; D-dimer
Sponsors: Insel Gruppe AG, University Hospital Bern
Recruiting
Development of MRF for Characterization of Brain Tumors After Radiotherapy

Posted: October 25th, 2023, 2:00am GMT

Conditions: Brain Tumor; Brain Necrosis; Brain Metastases
Interventions: Procedure: MRF in conjunction with IVIM MRI without contrast
Sponsors: Case Comprehensive Cancer Center; The Cleveland Clinic
Not yet recruiting
cCeLL - Ex Vivo (Confocal Fluorescence Endomicroscopy) for Intraoperative Brain Tumor Diagnosis

Posted: October 24th, 2023, 2:00am GMT

Conditions: Benign Brain Tumor; Malignant Brain Tumor
Interventions: Diagnostic Test: cCeLL Ex Vivo
Sponsors: VPIX Medical; Unity Health Toronto; Korea University Anam Hospital; Samsung Medical Center; Seoul National University Hospital
Not yet recruiting
A Clinical Trial on Combined (Neo-)Adjuvant Intravenous Plus Intracranial Administration of Ipilimumab and Nivolumab in Recurrent Glioblastoma

Posted: October 24th, 2023, 2:00am GMT

Conditions: Recurrent Glioblastoma
Interventions: Drug: Neo-adjuvant nivolumab and ipililumab IV + adjuvant nivolumab and ipililumab IV; Procedure: Neurosurgery and intracavitary injection nivolumab and ipililumab; Drug: Adjuvant nivolumab IV + nivolumab and ipililumab intracavitary
Sponsors: Universitair Ziekenhuis Brussel
Not yet recruiting
Regorafenib in Combination With Temozolomide With or Without Radiotherapy in Patients With Newly Diagnosed MGMT-Methylated, IDH Wild-type Glioblastoma.

Posted: October 23rd, 2023, 2:00am GMT

Conditions: Glioblastoma, IDH-wildtype; MGMT-Methylated Glioblastoma
Interventions: Drug: Regorafenib; Drug: Temozolomide
Sponsors: Istituto Oncologico Veneto IRCCS
Recruiting
18F-FAPI-RGD PET/CT in Various Tumor Types

Posted: October 23rd, 2023, 2:00am GMT

Conditions: Neoplasms
Sponsors: Sichuan Provincial People's Hospital
Recruiting
$Permalink for 'Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC'$
Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC

Posted: October 23rd, 2023, 2:00am GMT

Conditions: Head and Neck Cancer; Relapse; Recurrent; Refractory Cancer
Interventions: Drug: Cyclophosphamide; Drug: Fludarabine; Biological: Cell Therapy
Sponsors: UNC Lineberger Comprehensive Cancer Center; Bellicum Pharmaceuticals; University Cancer Research Fund at Lineberger Comprehensive Cancer Center
Not yet recruiting
Clinical Applicantion of Multi-Tracer PET/MR Imaging in Neurological Disorders/Disease

Posted: October 20th, 2023, 2:00am GMT

Conditions: Alzheimer Disease; Parkinson Disease; Epilepsy; Malignant Brain Tumor
Interventions: Device: PET/MR
Sponsors: Xuanwu Hospital, Beijing; Peking University Cancer Hospital & Institute; Shanghai Zhongshan Hospital; Wuhan TongJi Hospital; Henan Provincial People's Hospital; Sun Yat-sen University; Shanghai East Hospital of Tongji University; The First Affiliated Hospital with Nanjing Medical University; Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences; Shanghai Jiao Tong University School of Medicine
Recruiting
RE-irradiation of Diffuse MIdline Glioma paTients

Posted: October 20th, 2023, 2:00am GMT

Conditions: Diffuse Midline Glioma, H3 K27M-Mutant; Diffuse Intrinsic Pontine Glioma; Diffuse Glioma; Pontine Tumors; Thalamic Tumor; Brain Tumor, Pediatric
Interventions: Radiation: Re-irradiation
Sponsors: Rigshospitalet, Denmark; Aarhus University Hospital; Sahlgrenska University Hospital, Sweden; Karolinska University Hospital; Radiumhospitalet, Oslo University Hospital
Not yet recruiting
Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma

Posted: October 19th, 2023, 2:00am GMT

Conditions: Glioblastoma; Recurrent Glioblastoma; Resectable Glioblastoma
Interventions: Procedure: Biospecimen Collection; Procedure: Magnetic Resonance Imaging; Other: Medical Chart Review
Sponsors: Jonsson Comprehensive Cancer Center; National Cancer Institute (NCI)
Recruiting
LIBERTY: Liquid Biopsy to Diagnose and Monitor CNS Involvement in High-risk B Cell Non-Hodgkin Lymphoma

Posted: October 19th, 2023, 2:00am GMT

Conditions: Non-hodgkin Lymphoma, B Cell
Interventions: Diagnostic Test: ctDNA detection
Sponsors: Swiss Group for Clinical Cancer Research
Not yet recruiting
ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells

Posted: October 19th, 2023, 2:00am GMT

Conditions: Hodgkin Lymphoma; Relapse; Refractory
Interventions: Drug: Chemotherapy; Biological: Cell infusion
Sponsors: UNC Lineberger Comprehensive Cancer Center
Not yet recruiting
A Phase II Study of T-DXd Plus SRT in HER2-positive Breast Cancer Brain Metastases

Posted: October 18th, 2023, 2:00am GMT

Conditions: Breast Cancer; Brain Metastases; Radiotherapy
Interventions: Drug: Combination use of SRT with T-DXd
Sponsors: Fudan University
Not yet recruiting
Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks

Posted: October 18th, 2023, 2:00am GMT

Conditions: Sleep Apnea
Interventions: Other: Standard of Care; Behavioral: Personalized OSA Treatment
Sponsors: University of Miami; National Institute on Aging (NIA)
Not yet recruiting
Effects of Acute Exercise and Ibuprofen on Symptoms, Immunity, and Neural Circuits in Bipolar Depression

Posted: October 18th, 2023, 2:00am GMT

Conditions: Bipolar Depression
Interventions: Other: Exercise Session; Drug: Ibuprofen 800 mg; Other: Rest; Drug: Placebo
Sponsors: Laureate Institute for Brain Research, Inc.
Not yet recruiting
A Feasibility Analysis of an in Vivo CONVIVO Endomicroscopy During Brain Surgery.

Posted: October 17th, 2023, 2:00am GMT

Conditions: Brain Tumor
Interventions: Device: CONVIVO
Sponsors: Northwell Health
Recruiting
Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders

Posted: October 13th, 2023, 2:00am GMT

Conditions: Neurodevelopmental Disorders; Autism; Autism Spectrum Disorder; Fragile X Syndrome; Tuberous Sclerosis; 22Q11 Deletion Syndrome; 22Q11 Deletion; ADHD; Tic Disorders; Tourette Syndrome; Tourette Syndrome in Children; Tourette Syndrome in Adolescence; ADHD - Combined Type; ADHD Predominantly Inattentive Type; ADHD, Predominantly Hyperactive - Impulsive; Provisional Tic Disorder; Anxiety; Anxiety Disorders; Agoraphobia; Generalized Anxiety; Generalized Anxiety Disorder; Social Anxiety; Social Anxiety Disorder; Unspecified Anxiety Disorder; Other Specified Anxiety Disorders; Separation Anxiety
Interventions: Drug: Sertraline; Other: Placebo
Sponsors: Anagnostou, Evdokia, M.D.; Azrieli Foundation; Canadian Institutes of Health Research (CIHR); Ontario Brain Institute; Holland Bloorview Kids Rehabilitation Hospital; McMaster University; Western University; Queen's University; University of Alberta; Alberta Health services; St. Justine's Hospital; Dalhousie University; Unity Health Toronto; University of Toronto; The Hospital for Sick Children
Not yet recruiting
Study of Brain-Gut Function Reconstruction After Intersphincteric Resection for Ultra-Low Rectal Tumors

Posted: October 13th, 2023, 2:00am GMT

Conditions: Rectal Neoplasms
Interventions: Device: Transcranial magnetic stimulation; Device: Sham Transcranial magnetic stimulationt
Sponsors: Huashan Hospital
Recruiting
Multimodal Deep Learning for the Diagnosis and Assessment of Alzheimer's Disease

Posted: October 13th, 2023, 2:00am GMT

Conditions: Alzheimer Disease; Mild Cognitive Impairment
Interventions: Diagnostic Test: gait video; speech video; facial expression video;
Sponsors: First Hospital of China Medical University
Not yet recruiting
Impact of Confirmed Autoimmune Encephalitis on Brain Glucose Metabolism : a Prospective FDG PET Study

Posted: October 12th, 2023, 2:00am GMT

Conditions: Autoimmune Encephalitis
Interventions: Other: FDG PET
Sponsors: Assistance Publique - Hôpitaux de Paris
Not yet recruiting
A Study to Learn About Dacomitnib in Patients With Non-small Cell Lung Cancer Which Has Spread to the Brain.

Posted: October 10th, 2023, 2:00am GMT

Conditions: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: dacomitnib
Sponsors: Pfizer
Not yet recruiting
Lactoferrin in Patients With Hepatic Encephalopathy

Posted: October 9th, 2023, 2:00am GMT

Conditions: Hepatic Encephalopathy
Interventions: Drug: Lactoferrin Bovine
Sponsors: Al-Azhar University
Not yet recruiting
Study of BDTX-1535 in Recurrent High-Grade Glioma (HGG) Participants With EGFR Alterations or Fusions

Posted: October 9th, 2023, 2:00am GMT

Conditions: High Grade Glioma
Interventions: Drug: BDTX-1535
Sponsors: St. Joseph's Hospital and Medical Center, Phoenix; Ivy Brain Tumor Center; Barrow Neurological Institute
Recruiting
The Living With a Long-Term Condition Study

Posted: October 9th, 2023, 2:00am GMT

Conditions: Asthma; Atrial Fibrillation; Cancer; Cerebrovascular Disorders; Stroke; CKD; Copd; Fibromyalgia; Pain; Heart Diseases; Heart Disease Chronic; Dementia; Diabetes; Epilepsy; Heart Failure; High Blood Pressure; Hypertension; Hiv; AIDS; IBD; IBS; Liver Diseases; Long COVID; Lupus Erythematosus; Multiple Sclerosis; Obesity; Osteoarthritis; Arthritis; Rheumatoid Arthritis; Osteoporosis; Parkinson Disease; Sickle Cell Disease; Hepatitis; Endometriosis; PCOS; Neurological Disorder; POTS - Postural Orthostatic Tachycardia Syndrome; MND (Motor Neurone DIsease); Cystic Fibrosis; Migraine; Spondylitis; Celiac Disease; Hidradenitis Suppurativa; Eczema; ME/CFS
Interventions: Diagnostic Test: Living with LTC Questionnaire
Sponsors: King's College London
Recruiting
Dual-task Training Effects on Cognition in Breast Cancer Survivors: the BRAINonFIT Study (BRAINonFIT).

Posted: October 9th, 2023, 2:00am GMT

Conditions: Breast Cancer Survivors; Cognitive Impairment; Executive Dysfunction
Interventions: Behavioral: Exercise; Behavioral: Dual-Task Training; Behavioral: Health and Wellness
Sponsors: University of Seville
Not yet recruiting
Targeting Osteosarcopaenia and Multimorbidity for Frailty Prevention

Posted: October 9th, 2023, 2:00am GMT

Conditions: Stroke; Traumatic Brain Injury; Knee Osteoarthritis; Breast Cancer
Sponsors: Tan Tock Seng Hospital; Rehabilitation Research Institute of Singapore (RRIS); Woodlands Health (WH)
Not yet recruiting
Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer

Posted: October 9th, 2023, 2:00am GMT

Conditions: Breast Cancer; Brain Metastases
Interventions: Diagnostic Test: Brain Imaging with 18F-FES
Sponsors: Weill Medical College of Cornell University; GE Healthcare
Not yet recruiting
Effectiveness of Rehabilitation in Adults Suffering From Persistent Concussion Symptoms

Posted: October 6th, 2023, 2:00am GMT

Conditions: Postconcussion Syndrome; Mild Traumatic Brain Injury
Interventions: Other: Non-pharmacological Individualized rehabilitative therapy; Other: Non-pharmacological Usual care therapy
Sponsors: University Health Network, Toronto; NeuroCatch Inc.
Recruiting
Randomized Trial of Radiosurgery vs Sham for Spasticity Associated With Stroke, SCI and Cerebral Palsy

Posted: October 6th, 2023, 2:00am GMT

Conditions: Spasticity as Sequela of Stroke; Spastic Cerebral Palsy; Spasticity, Muscle
Interventions: Radiation: stereotactic radiosurgery (SRS) dorsal root rhizotomy radiomodulation; Other: Sham
Sponsors: Ohio State University; Varian Medical Systems; Centro Diagnostico Milano, Co-PI: Pantaleo Romanelli, MD
Recruiting
Cognitive Frailty and Oxygen-ozone Therapy

Posted: October 6th, 2023, 2:00am GMT

Conditions: Cognitive Frailty
Interventions: Other: Experimental: Oxygen-Ozone (O2-O3); Other: Active Comparator: Oxygen (O2); Other: Placebo Comparator: Placebo (Air)
Sponsors: IRCCS Centro San Giovanni di Dio Fatebenefratelli
Active, not recruiting
Don't be Late! Postponing Cognitive Decline and Preventing Early Unemployment in People With Multiple Sclerosis

Posted: October 5th, 2023, 2:00am GMT

Conditions: Multiple Sclerosis
Interventions: Behavioral: Strenghtening the brain; Behavioral: Strengthening the mind
Sponsors: Amsterdam UMC, location VUmc; Universiteit Leiden; Personal Fitness Nederland; MS Vereniging Nederland; Merck BV; Genzyme, a Sanofi Company; MS Sherpa
Recruiting
National Registry of Rare Kidney Diseases

Posted: October 4th, 2023, 2:00am GMT

Conditions: Adenine Phosphoribosyltransferase Deficiency; AH Amyloidosis; AHL Amyloidosis; AL Amyloidosis; Alport Syndrome; Atypical Hemolytic Uremic Syndrome; Autoimmune Distal Renal Tubular Acidosis; Autosomal Recessive Proximal Renal Tubular Acidosis; Autosomal Recessive Distal Renal Tubular Acidosis; Autosomal Dominant Polycystic Kidney Disease; Autosomal Recessive Polycystic Kidney Disease; Bartter Syndrome; BK Nephropathy; C3 Glomerulopathy With Monoclonal Gammopathy; C3 Glomerulopathy; Calciphylaxis; Crystalglobulinaemia; Crystal-storing Histiocytosis; Cystinosis; Cystinuria; Dense Deposit Disease; Dent Disease; Denys-Drash Syndrome; Dominant Hypophosphataemia With Nephrolithiasis and/or Osteoporosis; Drug Induced Fanconi Syndrome; Drug-Induced Hypomagnesemia; Drug-Induced Nephrogenic Diabetes Insipidus; Epilepsy, Ataxia, Sensorineural Deafness and Tubulopathy; Fabry Disease; Familial Hypomagnesemia With Hypercalciuria and Nephrocalcinosis; Familial Primary Hypomagnesemia With Hypocalcuria; Familial Primary Hypomagnesaemia With Normocalciuria; Familial Renal Glucosuria; Fanconi Renotubular Syndrome 1; Fanconi Renotubular Syndrome 2; Fanconi Renotubular Syndrome 3; Fibrillary Glomerulonephritis; Fibromuscular Dysplasia; Focal Segmental Glomerulosclerosis; Generalised Pseudohypoaldosteronism Type 1; Gitelman Syndrome; Heavy-Metal-Induced Fanconi Syndrome; Hepatocyte Nuclear Factor 1-Beta-Associated Monogenic Diabetes; Hereditary Renal Hypouricemia; Hereditary Hypophosphatemic Rickets With Hypercalciuria; Hyperuricaemic Nephropathy; IgA Nephropathy; Immunotactoid Glomerulonephritis With Organised Microtubular Mononoclonal Immunoglobulin Deposits; Inherited Renal Cancer Syndromes; Intracapillary Monoclonal IgM Without Cryoglobulin; Intraglomerular/Capillary Lymphoma/Leukaemia; Isolated Autosomal Dominant Hypomagnesaemia Glaudemans Type; Liddle Syndrome; Light Chain Cast Nephropathy; Light Chain Proximal Tubulopathy Without Crystals; Light Chain Proximal Tubulopathy With Crystals; Lowe Syndrome; Membranous Nephropathy; Membranoproliferative Glomerulonephritis; Medullary Cystic Kidney Disease; Minimal Change Nephropathy; Mitochondrial Disease Of The Kidney; Monoclonal Immunoglobulin Deposition Disease; Nail Patella Syndrome; Nephrogenic Diabetes Insipidus; Nephrogenic Syndrome of Inappropriate Antidiuresis; Nephronophthisis; Primary Hypomagnesemia With Secondary Hypocalcemia; Primary Hyperoxaluria; Proliferative Glomerulonephritis With Monoclonal IgG Deposits; Proximal Tubulopathy Without Crystals; Pseudohypoaldosteronism Type 1, 2A-2E; Pure Red Cell Aplasia; Retroperitoneal Fibrosis; Sickle Cell Nephropathy; Shiga Toxin Associated Haemolytic Uraemic Syndrome; Steroid Resistant Nephrotic Syndrome; Steroid-Sensitive Nephrotic Syndrome; Thin Basement Membrane Nephropathy; Thrombotic Microangiopathy With Monoclonal Gammopathy; Type 1 Cryoglobulinaemic Glomerulonephritis; Tuberous Sclerosis; Unclassified Monoclonal Gammopathy Of Renal Significance; Vasculitis
Sponsors: UK Kidney Association
Recruiting
LAmbre Versus AMPLATZER Amulet Left AtrIal Appendage Occluder for StRoke ProphylaxIs

Posted: September 29th, 2023, 2:00am GMT

Conditions: Left Atrial Appendage Occlusion
Interventions: Device: Left Atrial Appendage Occlusion
Sponsors: Deutsches Herzzentrum Muenchen; Lifetech Scientific (Shenzhen) Co., Ltd.
Not yet recruiting
Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells

Posted: September 29th, 2023, 2:00am GMT

Conditions: Glioblastoma Multiforme; Glycolytic Index; Epidermal Growth Factor Receptor
Interventions: Diagnostic Test: pH Measurement of in vivo tissue
Sponsors: Jonsson Comprehensive Cancer Center; National Center for Advancing Translational Sciences (NCATS)
Recruiting
Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer

Posted: September 28th, 2023, 2:00am GMT

Conditions: Brain Cancer; Glioblastoma; Metastatic Cancer; Leptomeningeal Metastasis; Recurrent Glioblastoma
Interventions: Drug: Trastuzumab deruxtecan
Sponsors: Memorial Sloan Kettering Cancer Center; AstraZeneca
Recruiting
PSMA-PET/CT to Assess the Expression of Specific Membrane Antigen (PSMA) in Patients With Progressive Triple-negative Breast Cancer.

Posted: September 28th, 2023, 2:00am GMT

Conditions: TNBC - Triple-Negative Breast Cancer
Interventions: Diagnostic Test: Ga-PSMA PET/CT
Sponsors: Jules Bordet Institute
Recruiting
Efficacy and Safety of Tislelizumab for Lung Adenocarcinoma With Asymptomatic Brain Metastatic

Posted: September 27th, 2023, 2:00am GMT

Conditions: Lung Adenocarcinoma
Interventions: Drug: Tislelizumab,Platinum
Sponsors: Hebei Medical University Fourth Hospital
Recruiting
Performance of Elucirem® in DSC-MRI Perfusion of Brain Gliomas

Posted: September 27th, 2023, 2:00am GMT

Conditions: Brain Tumor, Primary; Brain Tumor, Recurrent
Interventions: Drug: Elucirem; Drug: Dotarem
Sponsors: Guerbet
Recruiting
Feasibility of 18F-Fluciclovine PET/CT to Identify Brain Metastasis

Posted: September 27th, 2023, 2:00am GMT

Conditions: Brain Metastases
Interventions: Diagnostic Test: 18F-Fluciclovine (Axumin) PET/CT
Sponsors: University of Arizona; Blue Earth Diagnostics
Not yet recruiting
Use of Pulsed Low-dose Rate Re-irradiation for Recurrent Glioma (PULSAR)

Posted: September 26th, 2023, 2:00pm GMT

Conditions: Glioma
Interventions: Radiation: Pulsed low dose-rate radiotherapy (pLDRT)
Sponsors: Centro di Riferimento Oncologico - Aviano
Recruiting
Somatic Mosaicism in Twins Discordant for Childhood Cancer

Posted: September 26th, 2023, 2:00pm GMT

Conditions: Pediatric Central Nervous System Tumor; Central Nervous System Tumor; Discordant Twin; Somatic Mutation
Interventions: Other: Biospecimen collection; Other: Questionnaire Administration
Sponsors: Children's Oncology Group; National Cancer Institute (NCI)
Recruiting
Non-Invasive Brain Stimulation and Cognitive Training for Depressive Symptomatology Related to Breast Cancer (ONCODEP)

Posted: September 26th, 2023, 2:00pm GMT

Conditions: Depressive Symptoms; Cognitive Impairment
Interventions: Device: Transcranial Direct Current Stimulation; Device: Transcranial Alternating Current Stimulation; Device: tES sham; Device: Online Cognitive Training
Sponsors: University of Santiago de Compostela; Fundacin Biomedica Galicia Sur
Recruiting
Prognostic Indicators in Pituitary Adenoma Surgery: a Comprehensive Analysis of Surgical Outcomes and Complications.

Posted: September 25th, 2023, 2:00am GMT

Conditions: Pituitary Adenoma; Surgery-Complications
Sponsors: Central Hospital, Nancy, France
Completed
Lithium Treatment to Prevent Cognitive Impairment After Brain Radiotherapy

Posted: September 22nd, 2023, 2:00pm GMT

Conditions: Cognitive Impairment; Cognitive Decline; Radiotherapy Side Effect; Radiotherapy; Complications; Brain Tumor; Memory Impairment; Late Effect of Radiation
Interventions: Drug: Lithium; Drug: Placebo
Sponsors: Region Stockholm; Rigshospitalet, Denmark
Not yet recruiting
Progressive Relaxation Training Effect On Pain, Activity And Social Participation In Women With Tension-Type Headache And Migraine

Posted: September 22nd, 2023, 2:00am GMT

Conditions: Pain, Chronic; Migraine Disorders; Tension-Type Headache
Interventions: Other: PROGRESSIVE RELAXATION TRAINING
Sponsors: Hacettepe University
Recruiting
MR-Adaptive Radiation Therapy for Anal Cancer With EScalated-Treatment in a Risk-Optimized Approach

Posted: September 22nd, 2023, 2:00am GMT

Conditions: Anal Squamous Cell Carcinoma
Interventions: Radiation: Radiotherapy - Low risk group; Radiation: Radiotherapy - Standard risk group; Radiation: Radiotherapy - Intermediate risk group; Radiation: Radiotherapy - High risk group
Sponsors: University Health Network, Toronto
Recruiting
Preclinical Brain Tumor Models

Posted: September 21st, 2023, 2:00pm GMT

Conditions: Brain Metastases; Diffuse Gliomas
Interventions: Other: Fresh tumor sampling
Sponsors: Assistance Publique Hopitaux De Marseille
Recruiting
18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery

Posted: September 21st, 2023, 2:00pm GMT

Conditions: Brain Metastases; Brain Metastases, Adult; Brain Cancer
Interventions: Drug: 18F fluciclovine
Sponsors: Baptist Health South Florida; Blue Earth Diagnostics
Not yet recruiting
Reducing Cognitive Impairment in Glioma With Repetitive Transcranial Magnetic Stimulation and Cognitive Strategy Training

Posted: September 21st, 2023, 2:00pm GMT

Conditions: Cognitive Impairment; Glioma
Interventions: Device: repetitive transcranial magnetic stimulation (rTMS); Behavioral: cognitive strategy training
Sponsors: Amsterdam UMC, location VUmc
Not yet recruiting
T-DXd Therapy for HER2-low Breast Cancer Patients With Brain Metastases

Posted: September 21st, 2023, 2:00pm GMT

Conditions: Breast Cancer; Metastatic Breast Cancer
Interventions: Drug: Trastuzumab-Deruxtecan (T-DXd)
Sponsors: MedSIR; Daiichi Sankyo, Inc.
Not yet recruiting

1 2 3 ... 13

← PubMed - Rare CNS Tumor Trial - CNS Tumor →

Rare Cancer News & Clinical Trials » Trial - Brain Tumor

Feeds

Trial - Brain Tumor (100 unread)

Posted: December 4th, 2023, 3:00am GMT

Posted: December 1st, 2023, 3:00am GMT

Posted: November 30th, 2023, 3:00am GMT

Posted: November 29th, 2023, 3:00am GMT

Posted: November 29th, 2023, 3:00am GMT

Posted: November 28th, 2023, 3:00am GMT

Posted: November 27th, 2023, 3:00am GMT

Posted: November 27th, 2023, 3:00am GMT

Posted: November 24th, 2023, 3:00am GMT

Posted: November 22nd, 2023, 3:00am GMT

Posted: November 20th, 2023, 3:00am GMT

Posted: November 20th, 2023, 3:00am GMT

Posted: November 20th, 2023, 3:00am GMT

Posted: November 20th, 2023, 3:00am GMT

Posted: November 17th, 2023, 3:00am GMT

Posted: November 17th, 2023, 3:00am GMT

Posted: November 16th, 2023, 3:00am GMT

Posted: November 16th, 2023, 3:00am GMT

Posted: November 16th, 2023, 3:00am GMT

Posted: November 15th, 2023, 3:00am GMT

Posted: November 15th, 2023, 3:00am GMT

Posted: November 14th, 2023, 3:00am GMT

Posted: November 14th, 2023, 3:00am GMT

Posted: November 13th, 2023, 3:00am GMT

Posted: November 13th, 2023, 3:00am GMT

Posted: November 13th, 2023, 3:00am GMT

Posted: November 10th, 2023, 3:00am GMT

Posted: November 10th, 2023, 3:00am GMT

Posted: November 9th, 2023, 3:00am GMT

Posted: November 6th, 2023, 3:00am GMT

Posted: November 6th, 2023, 3:00am GMT

Posted: November 6th, 2023, 3:00am GMT

Posted: November 3rd, 2023, 2:00am GMT

Posted: November 3rd, 2023, 2:00am GMT

Posted: November 3rd, 2023, 2:00am GMT

Posted: November 2nd, 2023, 2:00am GMT

Posted: November 2nd, 2023, 2:00am GMT

Posted: November 2nd, 2023, 2:00am GMT

Posted: November 2nd, 2023, 2:00am GMT

Posted: November 2nd, 2023, 2:00am GMT

Posted: November 1st, 2023, 2:00am GMT

Posted: November 1st, 2023, 2:00am GMT

Posted: October 31st, 2023, 2:00am GMT

Posted: October 30th, 2023, 2:00am GMT

Posted: October 30th, 2023, 2:00am GMT

Posted: October 30th, 2023, 2:00am GMT

Posted: October 27th, 2023, 2:00am GMT

Posted: October 26th, 2023, 2:00am GMT

Posted: October 25th, 2023, 2:00am GMT

Posted: October 25th, 2023, 2:00am GMT

Posted: October 25th, 2023, 2:00am GMT

Posted: October 25th, 2023, 2:00am GMT

Posted: October 24th, 2023, 2:00am GMT

Posted: October 24th, 2023, 2:00am GMT

Posted: October 23rd, 2023, 2:00am GMT

Posted: October 23rd, 2023, 2:00am GMT

Posted: October 23rd, 2023, 2:00am GMT

Posted: October 20th, 2023, 2:00am GMT

Posted: October 20th, 2023, 2:00am GMT

Posted: October 19th, 2023, 2:00am GMT

Posted: October 19th, 2023, 2:00am GMT

Posted: October 19th, 2023, 2:00am GMT

Posted: October 18th, 2023, 2:00am GMT

Posted: October 18th, 2023, 2:00am GMT

Posted: October 18th, 2023, 2:00am GMT

Posted: October 17th, 2023, 2:00am GMT

Posted: October 13th, 2023, 2:00am GMT

Posted: October 13th, 2023, 2:00am GMT

Posted: October 13th, 2023, 2:00am GMT

Posted: October 12th, 2023, 2:00am GMT

Posted: October 10th, 2023, 2:00am GMT

Posted: October 9th, 2023, 2:00am GMT

Posted: October 9th, 2023, 2:00am GMT